>

MEETINGS / EVENTS

RSS

November 08 - 09 2014, 12:00 AM - 12:00 AM

ASA Quality Meeting 2014

January 23 - 25 2015, 12:00 AM - 12:00 AM

ASA PRACTICE MANAGEMENT 2015

June 26 - 28 2015, 12:00 AM - 12:00 AM

Annual Perioperative Surgical Home Summit

>

FDA MEDWATCH ALERTS

October 16, 2014

FDA MedWatch - LifeCare Flexible Intravenous Solutions by Hospira, Inc.: Recall - Potential for Leakage

Summary:

FDA MedWatch LifeCare Flexible Intravenous Solutions by Hospira Inc

October 13, 2014

FDA MedWatch - CareFusion EnVe and ReVel Ventilators: Class 1 Recall - Power Connection Failure

Summary:

FDA MedWatch CareFusion EnVe and ReVel Ventilators

October 13, 2014

FDA MedWatch - ICU Medical ConMed Stat2 Flow Controller: Class 1 Recall - Delivers Higher Flow Rate than Intended

Summary:

FDA MedWatch ICU Medical ConMed Stat2 Flow Controller

>

ASA FEATURED PRODUCT

Add this product to your shopping cart

Self-Education and Evaluation (SEE) Program

SKU: 30701-14CE

... Read more »

Single Copies, Member Price: $360

President Signs “Food and Drug Administration Safety and Innovation Act” Into Law; Includes Key ASA-Advanced Drug Shortage Provisions

Tuesday, July 10, 2012

On July 9, President Barack Obama signed into law S. 3187, the "Food and Drug Administration Safety Act" law, which contains important provisions to address drug shortages. Previously the legislation cleared the U.S. Senate by a vote of 92-4 and the U.S. House by a voice vote.

This law represents a major step forward in efforts to address drug shortages. Specifically, at the urging of ASA and other drug shortages stakeholders, lawmakers used this bill as a vehicle to address the national drug shortages issue and this law includes an entire title consisting of provisions intended to help prevent and mitigate drug shortages.

ASA President Jerry A. Cohen, M.D. offered the following remarks:

"We are pleased to report the successful passage and signing of the Food and Drug Administration Safety Act. ASA's consistent leadership and advocacy alongside other key stakeholders proved fruitful in advancing the key drug shortages provisions of this act."

Review the legislation as passed by the House of Representatives and the Senate.
Review a summary of the legislation.
Review ASA’s letter to the Senate and House negotiators.
Learn more about ASA’s work to address drug shortages.

« Back to Washington Alerts